Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
"Todays approval is another demonstration of what the FDA can accomplish when we try bold new things." The higher-dose GLP-1 is indicated to "reduce excess body weight and maintain weight reduction long-term in adults with obesity, or overweight with at least one weight-related condition," per the FDA's statement
Frequent missed doses lead to fluctuating medication levels, potentially causing more side effects and less consistent weight loss
Surgical interventions typically produce greater and more durable weight loss than pharmacotherapy alone and may be more appropriate than escalating to combination drug regimens with uncertain safety profiles
Effects of GLP-1RAs on Specific Inflammatory Skin Diseases While research is still ongoing, early indications are that GLP-1s may offer benefits for inflammatory skin diseases, including: Psoriasis immune dysregulation related to T cells and cytokines leads to systemic inflammation, skin discoloration, and thickening plaques
Tirzepatide makes the most sense for men who have plateaued on semaglutide, who need stronger appetite suppression, or who require more aggressive intervention for metabolic health reasons
\Cognitive Support: Improves spatial navigation in aged murine models
